Synthesis 2008(19): 3065-3070  
DOI: 10.1055/s-2008-1067264
PAPER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Substituted Imidazo[1,2-h][1,7]naphthyridines as H+/K+-ATPase Inhibiting Drug Precursors via Directed ortho-Metalation of Imidazo[1,2-a]pyridines

Jörg Senn-Bilfinger*, Bernhard Kohl, Georg Rainer, Wilm Buhr, Hans Christof Holst, Peter Jan Zimmermann
ALTANA Pharma AG, now Nycomed GmbH, Byk-Gulden-Str.2, 78467 Konstanz, Germany
Fax: +49(7531)8492505; e-Mail: joerg.senn-bilfinger@nycomed.com;
Weitere Informationen

Publikationsverlauf

Received 28 May 2008
Publikationsdatum:
05. September 2008 (online)

Zoom Image

Abstract

Selective directed ortho-metalation (DOM) of 2,3-di­methyl-8-(pivaloylamino)imidazo[1,2-a]pyridine in the 7-position was achieved with tert-butyllithium. Subsequent reaction of the lithiated derivative with tributylchlorostannane to the corresponding 7-trialkylstannyl analogue and palladium-catalyzed Stille acylation with 3-arylpropenoic acid chlorides in the presence of lithium chloride gave the corresponding 7-acylated imidazopyridines in good yields. Cyclization to the target imidazonaphthyridines, which are precursors in the synthesis of gastric H+/K+-ATPase inhibiting drugs, was achieved by treatment with strong acid. For scaled-up production of 2,3-dimethyl-9-phenyl-9,10-dihydroimidazo[1,2-h][1,7]naphthyridin-7(8H)-one, a tin-free process has been developed. Accordingly, the 7-lithiated 2,3-dimethyl-8-(pivaloyl­amino)imidazo[1,2-a]pyridine was reacted directly with cinnamaldehyde and the resultant alcohol oxidized with manganese dioxide to give the unsaturated 7-acylated imidazopyridine.